Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase NA 6Phase 2 6Phase EARLY_PHASE1 4Phase 3 3Phase 4 1Phase 2/3 1

Status

Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 1

Conditions

Prostatic Neoplasms 2Carcinoma, Hepatocellular 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × perflutren × Clear all
NCT06024772 2025-12-22

Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer

Thomas Jefferson University

Phase 3 Not yet recruiting
300 enrolled
Genitourinary

Prostatic Neoplasms

NCT05336786 2025-09-04

Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)

Thomas Jefferson University

Phase 3 Active not recruiting
70 enrolled
Genitourinary

Prostatic Neoplasms

NCT02764801 2025-05-06

Contrast-enhanced Ultrasound Evaluation of Chemoembolization

Thomas Jefferson University

Phase 3 Completed
131 enrolled 10 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡